Zobrazeno 1 - 10
of 69
pro vyhledávání: '"L. Villamayor"'
Autor:
L. Villamayor Blanco, G. Llimera Rausell, V. Jorge Vidal, C. González Pérez-Crespo, C. Iniesta Navalón, M.ª C. Mira Sirvent, M. Martínez Penella, S. Rabell Íñigo
Publikováno v:
Nutrición Hospitalaria, Vol 21, Iss 2, Pp 163-172 (2006)
Antecedentes y Objetivos: Las altas cifras iniciales de prevalencia de desnutrición en los enfermos hospitalizados-cercanos al 40%- es un dato preocupante. Esto permite deducir que la identificación precoz de enfermos desnutridos o en riesgo de est
Externí odkaz:
https://doaj.org/article/b2f0ffe9fd5c4ce886188b45bfd3833e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Acknowledgements This research was carried out with financial support from the Min- istry of Science, Innovation and Universities (Spain) (Research project number: RTI2018-095344-A-100), the Centre of Andalusian Studies (Research project number PR137
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03210ea36d6c56da1d89fca18f1d4db2
https://hdl.handle.net/10481/77036
https://hdl.handle.net/10481/77036
Autor:
B. Saavedra, M.G. López, Á. Chiner-Oms, A.M. García, I Cancino, M. Torres-Puente, L. Villamayor, C. Madrazo, E. Mambuque, VG. Sequera, D. Respeito, S. Blanco, O. Augusto, E. López-Varela, AL. García-Basteiro, I. Comas
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
Genomic studies of Mycobacterium tuberculosis complex (MTBC) might shed light on the dynamics of its transmission, especially in high-burden settings, where recent outbreaks are embedded in the complex natural history of the disease. We applied Whole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48ff5d7034f0f157c4391fed43f746d1
https://doi.org/10.1101/2022.02.01.22270230
https://doi.org/10.1101/2022.02.01.22270230
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
S Vázquez Blanco, JC De Miguel Bouzas, L Herrero Poch, L Villamayor Blanco, JM Castro Domínguez, S Fortes González
Publikováno v:
Section 1: Introductory statements and governance.
Background and importance High costs of biological medicines (BM) are a financial issue for hospitals. The arrival of biosimilar drugs (BS) improved their accessibilities by reducing their prices. Aim and objectives To analyse the costs of BM adminis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f0d115d4955f4fa69ed330759f56d69
https://doi.org/10.1136/ejhpharm-2021-eahpconf.11
https://doi.org/10.1136/ejhpharm-2021-eahpconf.11
Autor:
S Vázquez Blanco, S Fortes González, L Villamayor Blanco, L Herrero Poch, JM Castro Domínguez, JC De Miguel Bouzas
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance Alemtuzumab is a humanised monoclonal antibody that selectively targets CD52, indicated in adult patients with relapsing–remitting multiple sclerosis (RRMS). Aim and objectives To assess the effectiveness and safety of ale
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a10feab14836b14a4db8ab92812f08e6
https://doi.org/10.1136/ejhpharm-2020-eahpconf.378
https://doi.org/10.1136/ejhpharm-2020-eahpconf.378
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Eur J Hosp Pharm
Background Vedolizumab is a monoclonal antibody for the treatment of ulcerative colitis and Crohn’s disease. Purpose The aim of this study was to determine the effectiveness and safety of vedolizumab in our hospital since its inclusion in the pharm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b4e70334a55d2f0e8e343f0dd92769e
https://doi.org/10.1136/ejhpharm-2018-eahpconf.357
https://doi.org/10.1136/ejhpharm-2018-eahpconf.357
Publikováno v:
Eur J Hosp Pharm
Background Off-label use of medication is common in hospital clinical practice and should be applied together with follow-up of a healthcare treatment protocol and in compliance with a procedure which ensures that the patient is informed and that he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5546d398c6ff8d413aaccf3b84764076
https://doi.org/10.1136/ejhpharm-2018-eahpconf.457
https://doi.org/10.1136/ejhpharm-2018-eahpconf.457